Skip to content
Saturday, October 25, 2025
Latest:
  • Social Media’s impact on children
  • Dr. Rafael Tomoya Michita named 2025 STAT Wunderkind
  • Healthy Habits: Dr. Olivia Ginnard enjoys yoga, walking
  • Not cosmetic: How a breast implant saved a life
  • Some human GII.4 norovirus infect cells better than others; researchers have found an explanation
Baylor College of Medicine Blog Network

  • Home
  • Momentum
    • About Momentum
    • Resources
    • Contributors
      • Taylor Barnes
      • Dana Benson
      • Molly Chiu
      • Julie Garcia
      • Graciela Gutierrez
      • Anna Kiappes
      • Andy Phifer
      • Homa Shalchi
      • Melissa Tucker
    • Contact Us
  • From The Labs
    • About From the Labs
    • Follow From The Labs on Twitter
  • Policywise
    • About PolicyWise
    • Follow @BCMEthics on Twitter
  • The Stitch
    • About The Stitch
  • Progress Notes
    • About Progress Notes
    • Progress Notes Editors
    • Connect With Us
  • bcm.edu

cisplatin

From The Labs

A new mechanism of cisplatin resistance in cancer, and how to reverse it

April 22, 2021 ACTL6A,  cancer resistance to therapy,  cisplatin,  DNA repair,  epigenetic chromatin remodeling,  panobinostat,  Research

ACLT6A overexpression confers cancer cells resistance to cisplatin, and researchers found a way to reverse it.

Read More

From the Labs: Image of the Month

Close up of neurons from the brain cortex of a mouse with Huntington's disease. From the Labs: Neurons in a Huntington’s brain

Healthy Habits: A DOC-umentary Series

https://www.youtube.com/watch?v=SlNiMWHUhbc

Archives

Search

©1998 - 2023 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951